Guido Eibl
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer Genomics and Diagnostics
- Oncology top 5%
- Pancreatic and Hepatic Oncology Research
Papers in
-
- Natural product bioactivities and synthesis 4
- Cell death mechanisms and regulation 2
- Metabolism, Diabetes, and Cancer 2
- Extracellular vesicles in disease 2
- Pharmacology 11
- Flavonoids in Medical Research 6
- Inflammatory mediators and NSAID effects 2
- Co-authors
- O. Joe Hines (21 shared papers)Howard A. Reber (17 shared papers)Anna S. Gukovskaya (5 shared papers)Eliane Angst (8 shared papers)Vay Liang W. Go (9 shared papers)Aune Moro (6 shared papers)David W. Dawson (6 shared papers)Xuyang Lu (3 shared papers)
- Journals
- Pancreas (8 papers)Gastroenterology (6 papers)Surgery (3 papers)Journal of Surgical Research (3 papers)Biochimica et Biophysica Acta (BBA) - Molecular Cell Research (2 papers)
- Partner nations
- United StatesSwitzerlandGermany
In The Last Decade
Guido Eibl
31 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 91
- Cancer Research 316
- Oncology 470
- Pharmacology 235
- Biochemistry 59
- Molecular Biology 654
Countries citing papers authored by Guido Eibl
This map shows the geographic impact of Guido Eibl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guido Eibl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guido Eibl more than expected).
Fields of papers citing papers by Guido Eibl
This network shows the impact of papers produced by Guido Eibl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guido Eibl. The network helps show where Guido Eibl may publish in the future.
Co-authors
The 25 scholars most cited alongside Guido Eibl, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 208 | |
| 2 | 2011 | 153 | |
| 3 | 2013 | 122 | |
| 4 | 2011 | 118 | |
| 5 | 2012 | 109 | |
| 6 | 2012 | 94 | |
| 7 | 2011 | 81 | |
| 8 | 2005 | 79 | |
| 9 | 2012 | 77 | |
| 10 | 2008 | 70 | |
| 11 | 2011 | 56 | |
| 12 | 2008 | 51 | |
| 13 | 2013 | 44 | |
| 14 | 2011 | 38 | |
| 15 | 2008 | 37 | |
| 16 | 2009 | 36 | |
| 17 | 2010 | 26 | |
| 18 | 2010 | 24 | |
| 19 | 2018 | 14 | |
| 20 | 2021 | 13 |
About Guido Eibl
Guido Eibl is a scholar working on Molecular Biology, Pharmacology, Oncology, Surgery and Cancer Research, having authored 31 papers that have together received 1.5k indexed citations. Recurring topics across this work include Flavonoids in Medical Research (6 papers), Pancreatic and Hepatic Oncology Research (6 papers), Natural product bioactivities and synthesis (4 papers), Inflammatory mediators and NSAID effects (2 papers), Cell death mechanisms and regulation (2 papers), Metabolism, Diabetes, and Cancer (2 papers), Chromatography in Natural Products (2 papers) and Extracellular vesicles in disease (2 papers). The work is most often cited by research in Cancer Research (316 citations), Oncology (470 citations), Pharmacology (235 citations), Biochemistry (59 citations) and Molecular Biology (654 citations). Guido Eibl has collaborated with scholars based in United States, Switzerland and Germany. Frequent co-authors include O. Joe Hines, Howard A. Reber, Anna S. Gukovskaya, Eliane Angst, Vay Liang W. Go, Aune Moro, David W. Dawson, Xuyang Lu, Graham Donald and Kathleen M. Hertzer. Their work appears in journals such as Pancreas, Gastroenterology, Surgery, Journal of Surgical Research and Biochimica et Biophysica Acta (BBA) - Molecular Cell Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.